BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11904756)

  • 41. Chronic alcohol consumption does not cause hippocampal neuron loss in humans.
    Harding AJ; Wong A; Svoboda M; Kril JJ; Halliday GM
    Hippocampus; 1997; 7(1):78-87. PubMed ID: 9138671
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hippocampal CA1 cell loss in a non-human primate model of transient global ischemia: a pilot study.
    Hara K; Yasuhara T; Matsukawa N; Maki M; Masuda T; Yu G; Xu L; Tambrallo L; Rodriguez NA; Stern DM; Kawase T; Yamashima T; Buccafusco JJ; Hess DC; Borlongan CV
    Brain Res Bull; 2007 Sep; 74(1-3):164-71. PubMed ID: 17683803
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A role for semaphorin 3A signaling in the degeneration of hippocampal neurons during Alzheimer's disease.
    Good PF; Alapat D; Hsu A; Chu C; Perl D; Wen X; Burstein DE; Kohtz DS
    J Neurochem; 2004 Nov; 91(3):716-36. PubMed ID: 15485501
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transneuronally altered dendritic processing of tangle-free neurons in Alzheimer's disease.
    Ohm TG; Münch S; Schönheit B; Zarski R; Nitsch R
    Acta Neuropathol; 2002 May; 103(5):437-43. PubMed ID: 11935258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vivo neuropathology of the hippocampal formation in AD: a radial mapping MR-based study.
    Frisoni GB; Sabattoli F; Lee AD; Dutton RA; Toga AW; Thompson PM
    Neuroimage; 2006 Aug; 32(1):104-10. PubMed ID: 16631382
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains.
    Lüth HJ; Ogunlade V; Kuhla B; Kientsch-Engel R; Stahl P; Webster J; Arendt T; Münch G
    Cereb Cortex; 2005 Feb; 15(2):211-20. PubMed ID: 15238435
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Remodeling of ammon's horn during the first two weeks of experimental diabetes development.
    Lebed YV; Orlovsky MA; Tsupikov OM; Pivneva TA; Skibo GG
    Fiziol Zh (1994); 2008; 54(3):52-6. PubMed ID: 18763580
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Volume and number of neurons of the human hippocampal formation in normal aging and Alzheimer's disease.
    Simić G; Kostović I; Winblad B; Bogdanović N
    J Comp Neurol; 1997 Mar; 379(4):482-94. PubMed ID: 9067838
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regional and cellular pathology in frontotemporal dementia: relationship to stage of disease in cases with and without Pick bodies.
    Kersaitis C; Halliday GM; Kril JJ
    Acta Neuropathol; 2004 Dec; 108(6):515-23. PubMed ID: 15368070
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Altered expression of COX-2 in subdivisions of the hippocampus during aging and in Alzheimer's disease: the Hisayama Study.
    Fujimi K; Noda K; Sasaki K; Wakisaka Y; Tanizaki Y; Iida M; Kiyohara Y; Kanba S; Iwaki T
    Dement Geriatr Cogn Disord; 2007; 23(6):423-31. PubMed ID: 17457030
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An analysis of atrophy in the medial mammillary nucleus following hippocampal and fornix lesions in humans and nonhuman primates.
    Loftus M; Knight RT; Amaral DG
    Exp Neurol; 2000 May; 163(1):180-90. PubMed ID: 10785457
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Research on nucleolar organizer regions of hippocampal neuron in Alzheimer's disease.
    Lu W; Tang H; Fan M; Mi R; Wang L; Jia J
    Chin Med J (Engl); 1998 Mar; 111(3):282-4. PubMed ID: 10374436
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alzheimer's disease: transiently developing dendritic changes in pyramidal cells of sector CA1 of the Ammon's horn.
    Braak E; Braak H
    Acta Neuropathol; 1997 Apr; 93(4):323-5. PubMed ID: 9113196
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease.
    West MJ; Coleman PD; Flood DG; Troncoso JC
    Lancet; 1994 Sep; 344(8925):769-72. PubMed ID: 7916070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alzheimer's disease: is the decrease of the cholinergic innervation of the hippocampus related to intrinsic hippocampal pathology?
    Ransmayr G; Cervera P; Hirsch EC; Berger W; Fischer W; Agid Y
    Neuroscience; 1992; 47(4):843-51. PubMed ID: 1374541
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An immunohistochemical study of the serotonin 1A receptor in the hippocampus of subjects with Alzheimer's disease.
    Mizukami K; Ishikawa M; Akatsu H; Abrahamson EE; Ikonomovic MD; Asada T
    Neuropathology; 2011 Oct; 31(5):503-9. PubMed ID: 21269332
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regionally specific loss of neurons in the aging human hippocampus.
    West MJ
    Neurobiol Aging; 1993; 14(4):287-93. PubMed ID: 8367010
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of chronic alcoholism on the human hippocampus.
    Bengochea O; Gonzalo LM
    Histol Histopathol; 1990 Jul; 5(3):349-57. PubMed ID: 2134390
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease.
    Price JL; Ko AI; Wade MJ; Tsou SK; McKeel DW; Morris JC
    Arch Neurol; 2001 Sep; 58(9):1395-402. PubMed ID: 11559310
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acetylcholinesterase-rich pyramidal neurons in the human neocortex and hippocampus: absence at birth, development during the life span, and dissolution in Alzheimer's disease.
    Mesulam MM; Geula C
    Ann Neurol; 1988 Dec; 24(6):765-73. PubMed ID: 3207359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.